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Background: Campylobacter jejuni and C. coli are human intestinal pathogens that are the most frequent causes of
bacterial foodborne gastroenteritis in humans in the UK. In this study, we aimed to characterise the metabolic
diversity of both C. jejuni and C. coli using a diverse panel of clinical strains isolated from the UK, Pakistan and
Thailand, thereby representing both the developed and developing world. Our aim was to apply multi genome
analysis and Biolog phenotyping to determine differences in carbon source utilisation by C. jejuni and C. coli strains.
Results: We have identified a core set of carbon sources (utilised by all strains tested) and a set that are
differentially utilised for a diverse panel of thirteen C. jejuni and two C. coli strains. This study used multi genome
analysis to show that propionic acid is utilised only by C. coli strains tested. A broader PCR screen of 16 C. coli
strains and 42 C. jejuni confirmed the absence of the genes needed for propanoate metabolism.
Conclusions: From our analysis we have identified a phenotypic method and two genotypic methods based on
propionic utilisation that might be applicable for distinguishing between C. jejuni and C. coli.
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Campylobacter species are a major cause of food-borne
disease in the developed and the developing world. Over
80% of human cases are caused by Campylobacter jejuni
and around 10% by Campylobacter coli, with the re-
maining human cases caused by other Campylobacter
species. The species C. jejuni and C. coli are considered
to be commensals of birds, domestic pets and livestock,
but they have also been isolated from other sources
including water, molluscs, bank voles and milk [1,2].
Disease in humans is most frequently associated with
the consumption of contaminated poultry (C. jejuni) or
porcine products (C. coli) [3].
Some past studies have begun to define the metabolic
requirements of C. jejuni, [4-7], yet there is still a pau-
city of information regarding the metabolic flexibility of* Correspondence: S.Wagley@exeter.ac.uk
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unless otherwise stated.this bacterium, which is able to survive in such a wide
range of environmental niches. It is well recognised that
amino acids are important carbon and energy sources
for C. jejuni, both in vitro and in vivo [8-11]. Serine,
aspartic acid, glutamic acid and proline are the most
common amino acids found in chicken faeces [4,12] and
are therefore possible nutrient sources for C. jejuni in
the chicken gut. C. jejuni preferentially metabolises
amino acids in a specific order: serine, aspartatic acid,
asparagine and then glutamic acid. Proline can also be
metabolised, but only after other nutrients have been
exhausted [13].
Campylobacter species were considered to be asaccha-
rolytic and thus unable to metabolise glucose or other car-
bohydrates due to the absence of the glycolytic enzyme
phosphofructokinase of the Embden-Meyerhof-Parnas
(EMP) pathway and incomplete pentose phosphate (PPP)
and Entner Doudoroff (ED) pathways [10,14]. However, it
was recently shown that a novel L-fucose pathway inclu-
ding L-fucose permease is present within a genomic islandLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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strated that some C. jejuni strains can metabolise the
sugar L-fucose. Furthermore, Stahl and co-workers found
that fucose transport in C. jejuni in vivo provided these
strains with a competitive advantage during colonisation
of the piglet infection model [4]. However, there have
been no subsequent reports of C. jejuni carbohydrate
metabolism.
Citric acid cycle intermediates such as pyruvate, fumar-
ate, oxaloacetate and 2-oxoglutarate, succinate, fumarate
and malate have been reported as energy sources for
C. jejuni [6,10,16]. In addition, C. jejuni has been reported
to metabolise short-chain fatty acids (SCFA) [9,13].
Acetate, propionate and butyrate are the most significant
anion or salt derivatives of SCFAs that are produced as
metabolic by-products from the gut microbiota [17].
The capacity for Campylobacter species to survive and
thrive in a wide range of environmental niches is under-
pinned by the ability of the bacteria to utilise the dif-
ferent metabolites that are available in the various hosts
and environments. In contrast to the C. jejuni studies
described above, very little is known about the metabolic
requirements of C. coli. In this study, we aimed to
characterise the metabolic profile of both C. jejuni and
C. coli in order to see differences in their carbon utilisa-
tion capabilities. We used a diverse panel of clinical
strains isolated from UK, Pakistan and Thailand, re-
presenting both the developed and developing world
(Table 1). From our analysis we have identified a pheno-
typic method and two genotypic methods for distin-
guishing between C. jejuni and C. coli.
Results
Carbon utilisation profiles of C. jejuni and C. coli strains
reveal core and variable metabolites
We initially selected 13 human C. jejuni isolates and two
human C. coli isolates to assess their metabolic profiles.
Using BIOLOG PM1 and PM2 carbon utilisation plates,
we identified the core (utilised by 100% of strains tested)
and differential carbon sources (utilised by <90% of
strains tested) utilised by a diverse panel of 13 C. jejuni
and two C. coli strains (Table 2). The Omnilog software
(Hayward, California USA) generates a reading every 15
mins corresponding to the conversion of the redox dye
used in the assay and hence respiration levels. The entire
experiment was repeated at least in triplicate for each
strain. The mean values of the experimental replicates
for each strain for each carbon substrate were compared
by one way ANOVA and Tukey multiple comparison of
means using a 95% family-wise confidence level. Statis-
tical significance was assigned at the P < 0.05 level (see
Additional file 1). Core carbon sources included the
amino acids L-aspartic acid, L-asparagine, L-proline and
L-serine. Citric acid cycle intermediate succinic acid andits derivative bromo-succinic acid were used by all
strains. D,L malic acid, fumaric acid and methyl pyruvic
acid were also metabolised by all of the strains. When
D-malic acid was used as a sole carbon source it was
only utilised by C. jejuni strains and not by the two
C. coli strains tested. Lactic acid, butyric acid and D-lactic
acid methyl ester were utilised by all strains while formic
acid was utilised by 14 of the 15 strains tested.
Differential carbon sources (utilised by <90% of tested
strains) included the carbohydrate L-fucose, supporting
recent reports that some strains of C. jejuni are able to
utilise carbohydrates [4]. We found differential metabo-
lism of the amino acids L-glutamine, glycyl-L-glutamic
acid and glycine-L-proline and citric acid cycle interme-
diates alpha-keto-glutaric acid, citric acid, glycolic acid,
glyoxylic acid, tricarballyic acid. The metabolic profiles
of all the strains can be found in Additional file 1.
Finally, the SCFA propionic acid, was metabolised by
both C. coli strains tested (K3 and K7) but was not
metabolised by any of the C. jejuni strains (Table 2).
Whole-genome sequencing reveals genes encoding
propanoate metabolism enzymes in C. coli that are
absent from C. jejuni
To identify the genetic basis for propionic acid metabol-
ism in C. coli, we sequenced the genomes of two C. coli
strains (isolated from individuals suffering from diarrhoeal
disease in Pakistan (Table 1). Data from these whole-
genome shotgun projects have been deposited at DDBJ/
EMBL/GenBank under the accessions AYKO00000000
and AYKN00000000. The versions described in this paper
are version AYKO01000000 and AYKN00000000. We
used the RAST webserver [23] to examine the presence or
absence of enzymes in the propanoate metabolism path-
way (KEGG: ko00640) for C. jejuni strains NCTC 11168
[22], 81116 [19] and 81176 [20] and C. coli strains K3 and
K7 and found that genes encoding propionate-CoA ligase
(PrpE/EC 6.2.1.17) and 2-methyl-citrate synthase (PrpC/
EC 2.3.3.5) were present in the genomes of both C. coli
strains but were absent from the C. jejuni genome se-
quences (see Figure 1).
To assess whether the presence or absence of
propionate-CoA ligase and 2-methyl-citrate synthase
genes could be used to distinguish C. coli from C. jejuni,
we next searched the NCBI non-redundant nucleotide
sequence database [24] for similar sequences using Blastn
[25]. We also performed these searches against the 66
publicly available complete and draft C. coli genome
sequences in RefSeq [26]. Homologues of propionate-CoA
ligase and 2-methyl-citrate synthase genes were identified
in all (66/66) of the C. coli genomes interrogated and with
a minimum of 99% identity across the entire gene
sequences. In contrast, when the 84 publicly available
C. jejuni complete and draft genomes were interrogated
Table 1 List of C. jejuni and C. coli strains used in this study
Species Strain name Source Country of origin 2-methylcitrate synthase Propionate-CoA ligase gltA Strain source
C. coli 1/12 Human UK + + + This study
C. coli 90-3 - - NT NT NT AIMJ01000007.1
C. coli 2548 - - NT NT NT AIML01000019.1
C. coli JV 20 - USA NT NT NT AEER01000027.1
C. coli K3* Human Pakistan + + + This study
C. coli K7* Human Pakistan + + + This study
C. coli PS304* Pig UK + + + This study
C. coli R03/167* Cattle UK + + + This study
C. coli R03/389* Sheep UK + + + This study
C. coli R03/393* Cattle UK + + + This study
C. coli R04/28* Sheep UK + + + This study
C. coli RM 2228 Chicken USA NT NT NT [18]
C. coli S03/35* Pig UK + + + This study
C. coli S03/468* Cattle UK + + + This study
C. coli S03/475* Pig UK + + + This study
C. coli S03/704* Pig UK + + + This study
C. coli S03/749* Sheep UK + + + This study
C. coli S03/954* Sheep UK + + + This study
C. coli S39-2-99-3* Sheep UK + + + This study
C. coli Z163 - - NT NT NT AIMK01000002.1
C. coli MB17 Poultry UK + + + This study
C. jejuni 74 Goose - - - + This study
C. jejuni 95* Goose - - - + This study
C. jejuni 91B1 Chicken - - - + This study
C. jejuni 99/201 Cow UK - - + This study
C. jejuni 99/212 Human UK - - + This study
C. jejuni 222* Goose - - - + This study
C. jejuni 11818 Human UK - - + This study
C. jejuni 11919* Human UK - - + This study
C. jejuni 11974* Human UK - - + This study
C. jejuni 12241* Human UK - - + This study
C. jejuni 13305* Human UK - - + This study
C. jejuni 18629 Unknown - - - + This study
C. jejuni 18836* Unknown - - - + This study
C. jejuni 30280* Human UK - - + This study
C. jejuni 30328* Unknown - - - + This study
C. jejuni 31407 Unknown - - - + This study
C. jejuni 31481 Unknown - - - + This study
C. jejuni 31484 Human UK - - + This study
C. jejuni 31485 Human UK - - + This study
C. jejuni 32787 Human UK - - + This study
C. jejuni 32799* Human UK - - + This study
C. jejuni 33084* Human UK - - + This study
C. jejuni 33106 Human UK - - + This study
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Table 1 List of C. jejuni and C. coli strains used in this study (Continued)
C. jejuni 34007 Human UK - - + This study
C. jejuni 40483 Unknown - - - + This study
C. jejuni 41730 Unknown - - - + This study
C. jejuni 44119* Human UK - - + This study
C. jejuni 47693* Human UK - - + This study
C. jejuni 81116* Human - NT NT NT [19]
C. jejuni 81176* Human USA NT NT NT [20]
C. jejuni 81205 Unknown - - - + This study
C. jejuni A6.T2.15* Poultry UK - - + This study
C. jejuni A8.35.15A* Poultry UK - - + This study
C. jejuni ATCC 43431 Human - - - + [21]
C. jejuni BB1267* Human UK - - + This study
C. jejuni C1/C/2* Poultry UK - - + This study
C. jejuni C5/T2/8 Poultry UK - - + This study
C. jejuni Cj1* Human Thailand - - + This study
C. jejuni Cj2* Human Thailand NT NT NT This study
C. jejuni Cj3*† Human Thailand NT NT NT This study
C. jejuni Cj5* Human Thailand - - + This study
C. jejuni D2/T/8 Poultry UK - - + This study
C. jejuni D2/T/95 Poultry UK - - + This study
C. jejuni K1* Human Pakistan NT NT NT This study
C. jejuni K2* Human Pakistan NT NT NT This study
C. jejuni K4* Human Pakistan NT NT NT This study
C. jejuni K5* Human Pakistan NT NT NT This study
C. jejuni K6* Human Pakistan - - + This study
C. jejuni MB16 Poultry UK - - + This study
C. jejuni MB18 Poultry UK - - + This study
C. jejuni NCTC11168* Human - - - + [22]
†indicates those strains that have their genomes fully sequenced. C. coli strains K3 (AYKN00000000) and K7 (AYKO00000000) had their genomes sequenced in the
scope of this study.
*indicates those strains used in the Biolog studies. NT indicates strains not tested.
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CoA ligase or 2-methyl-citrate synthase.
A PCR assay for the propionate-CoA ligase or 2
methyl-citrate-synthase genes can be used to distinguish
C. coli from C. jejuni
An amino acid sequence alignment of propionate-CoA
ligase and 2-methyl-citrate-synthase from C. coli re-
vealed that these proteins are highly conserved across
six randomly selected C. coli isolates (see Additional
file 2). PCR amplification of the propionate-CoA ligase or
2-methyl-citrate synthase genes using C. coli or C. jejuni
template DNA generated amplicons of the expected size
from all 15 strains of C. coli tested. In contrast, amplicons
were not generated using template DNA from 42 of 43
strains of C. jejuni tested. The single isolate (MB17 pre-
viously characterised as C. jejuni) that generated PCRamplicons was subsequently shown to give a negative re-
action in the hippurate hydrolysis assay, indicating that
this strain had been incorrectly assigned as C. jejuni.
Therefore, 100% (42/42) of the C. jejuni strains failed to
yield amplicons. Positive-control PCR assays for the
housekeeping gene gltA (encoding citrate synthase) gene-
rated amplicons from all of the C. jejuni and C. coli iso-
lates tested.
Propionic acid as a sole carbon source allows differential
identification of C. coli and C. jejuni
To determine whether C. coli and C. jejuni differed in
their ability to utilise propionic acid as a sole carbon
source in culture medium, we tested a panel of 16 en-
vironmental and clinical C. coli strains and 17 C. jejuni
strains in BIOLOG phenotypic microarray plates contai-
ning propionic acid as the sole carbon source. No or weak
Table 2 Core and differential carbon sources utilised by strains used in this study
Carbon source C. jejuni C. coli
K1 K2 K4 K5 K6 81176 81116 11168 32799 33084 Cj1 Cj2 Cj5 K3 K7
Amino Acids L-Proline + + + + + + + + + + + + + + +
L-Asparagine + + + + + + + + + + + + + + +
L-Serine + + + + + + + + + + + + + + +
L-Aspartic Acid + + + + + + + + + + + + + + +
L-Glutamic Acid + + + + + + - + + - + + - + +
L-Glutamine + + + + + + + + + - + + - + +
Citric Acid Intermediates Methyl Pyruvate + + + + + + + + + + + + + + +
L-Malic Acid + + + + + + + + + + + + + + +
Succinic Acid + + + + + + + + + + + + + + +
D,L-Malic Acid + + + + + + + + + + + + + + +
Bromo Succinic Acid + + + + + + + + + + + + + + +
Fumaric Acid + + + + + + + + + + + + + + +
Mono Methyl Succinate + + + + + + + - + + + - + + +
D-Malic Acid + + + + + + + + + + + + + - -
Carboxylic Acids L-Lactic Acid + + + + + + + + + + + + + + +
D-Lactic Acid Methyl Ester + + + + + + + + + + + + + + +
a-Hydroxy Butyric Acid + + + + + + + + + + + + + + +
Formic Acid + + + + + + + + - + + + + + +
Propionic Acid - - - - - - - - - - - - - + +
Carbohydrates L-Fucose - - - - - - - - + - + - - + +
The carbon sources that are core to all the strains have been highlighted in bold.
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while strong propionic utilisation was seen for all C. coli
strains tested. The mean values of the experimental re-
plicates for each strain were compared using a unpaired
T test with Welch’s correction. Statistical significance was
assigned at P < 0.0001 level indicating a difference between
propionic utilisations by C. jejuni and C. coli. Figure 2
shows levels of propionic acid utilisation by C. jejuni and
C. coli strains.
Discussion
Campylobacter species are fastidious bacteria, exhibiting
significant metabolic restrictions compared to other en-
teropathogenic bacteria. The principal energy sources
for C. jejuni are amino acids, citric acid cycle interme-
diates and short-chain fatty acids [10,27]. Despite these
metabolic limitations, Campylobacter species can survive
in a wide range of environmental niches suggesting
metabolic flexibility. To date, only a few laboratory
adapted strains have been used to study the metabolic
diversity of Campylobacter species. In this study, we ex-
amined the extent of the metabolic diversity of C. jejuni
and C. coli recently isolated from cases of disease.
The catabolism of amino acids by C. jejuni not only
provides a carbon source but also protects bacteria fromosmotic and oxidative stress [28-30]. Moreover, catabo-
lism of particular amino acids can confer tissue-specific
advantages for C. jejuni colonisation [11]. Hofreuter and
co-workers showed that serine supports growth of
C. jejuni in murine intestinal and liver tissue, whereas
proline and glutamine support growth in the intestine
but not the liver [11]. They also showed that two
C. jejuni strains (ATCC 33251 and RM1221) were un-
able to utilise serine in vitro even though they showed
no genetic variation in L-serine dehydratase (SdaA) and
the serine transporter SdaC. We have shown in this
study that L-serine was utilised by all 13 C. jejuni tested.
Amino acids that were differentially utilised by the
C. jejuni and C. coli strains included L-glutamine, and
glutamic acid. This difference in the metabolic profiles
of C. jejuni and C. coli isolates may indicate adaptation
of these strains to different niches and reflect niche spe-
cific requirements for amino acids as a nutrient source,
such as those reported for Staphylococcus aureus and
Francisella novicida [31,32].
Previous studies have concluded that except for a few
strains that are able to utilise the carbohydrate L-fucose
[4,10], Campylobacter are asaccharolytic. One of the
strains shown in previous studies [4,15] to utilise fucose
was C. jejuni strain NCTC 11168. In our study, we
Figure 1 Propanoate metabolism pathway in C. jejuni and C. coli. Each box stands for an enzyme in the propanoate metabolism pathway. The
yellow boxes indicate the ortholog genes shared by both C. jejuni and C. coli (ptA-phosphate acetyltrasferase, AckA-acetate kinase, AcS-acetyl-CoA
synthetase and SucD- succinyl-CoA synthetase) while the green boxes indicates those genes present only in C. coli strains (PrpE- propionate-CoA ligase
and PrpC-2-methyl citrate synthase).
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using this carbon source. Other workers have reported
differences in strains of NCTC 11168 which may ac-
count for this phenotype [33,34]. Furthermore, in a pre-
vious study it has been shown that oxidation of some
substrates was greater at 42°C than 37°C. This may ac-
count for the lack of L-fucose utilisation seen here [35].
The ability of some strains of C. jejuni to utilise L-fucose
is reportedly associated with the colonisation of pigs, but
not poultry [4]. The two C. coli strains we tested using
the BIOLOG assay were both able to utilise L-fucose. As
C. coli is predominately found in pigs, our findings sup-
port the suggestion [4] that fucose availability in the pig
intestine influences the bacterial fitness of C. coli colo-
nisation in this host.
From our study, we found that none of the C. jejuni
isolates tested were able to metabolise propionic acid
while both C. coli strains were able to metabolise this
carbon source. This appears to be linked to the presenceof propanoate-CoA ligase and 2-methyl-synthase genes
in C. coli and their absence in C. jejuni. Our studies fur-
ther showed that the absence or presence of these genes
is a reliable marker for the identification of C. jejuni or
C. coli. The power of this test was confirmed by our
finding that strain MB17 has been erroneously identified
as C. jejuni; this strain tested positive for these two
marker genes and our subsequent investigations showed
that this was a strain of C. coli.
Propionic acid is the most abundant of four SCFA
measured in pig manure [36] and levels of propionate
have been reported to be high in the gastrointestinal
tract of pigs, one of the natural hosts for C. coli [37].
Competition for nutrients in the gut is fierce and so the
ability to use a potentially toxic metabolic waste product
as an energy source may confer C. coli with a selective
advantage when colonising the pig gastrointestinal tract.
Campylobacterioisis is the principal cause of bacterial
diarrhoeal disease in humans and C. jejuni and C. coli
Figure 2 Histogram representing propionic utilisation by C. jejuni and C. coli strains. The C. jejuni strains have been grouped together in
grey bars while all C. coli strains have been grouped by black bars. No or only weak propionic utilisation was seen in all C. jejuni strains tested
(values below an OD of 0.4) while high propionic utilisation was seen for all C. coli strains tested (values above an OD of 0.5).
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pylobacteriosis. The epidemiology of Campylobacter in-
fections in humans is poorly characterised in low income
countries [38]. The true incidence of C. coli is difficult to
estimate due to the difficulties in distinguishing Campylo-
bacter species. C. jejuni can be distinguished from other
Campylobacter species on the basis of the hydrolysis of
hippurate for which C. jejuni gives only a positive reaction.
However, hippurate negative C. jejuni strains have occa-
sionally been reported [39,40]. Mass spectrometry has also
been used to discriminate between Campylobacter species
C. coli, C. jejuni, C. helveticus, C. lari, C. sputorum and C.
upsaliensis using species identifying biomarkers [41].
However, these methods are time consuming and require
complex equipment. Often additional confirmatory tests
based upon PCR amplification of a range of genes are
needed [42-44]. For example Klena et al., describes a
multiplex PCR test to distinguish between C. jejuni, C.
coli, C. coli, C. lari and C. upsaliensis using the lipid A
gene lpxA with good species identification.
Conclusion
Methods that distinguish species of Campylobacter need
to be developed in order to understand environmentalaspects of Campylobacter epidemiology, the emergence
of atypical Campylobacter species, emerging clinical
aspects of disease, the association of Campylobacter
species with their natural hosts and emerging trends in
antibiotic resistance. We have presented a molecular
method that allows for accurate discrimination of the
two predominant species associated with human disease.
In addition, we have identified the basis for a selective
media that would permit rapid discrimination of C.
jejuni and C. coli that would be suitable for use in diag-
nostic and reference laboratories around the world. The
importance of identifying C. coli from C. jejuni correctly
from both environmental and clinical sources would
help broaden our understanding of the distribution,
prevalence, geographical spread and transmission of this
human pathogen.
Methods
Strains and culture conditions
All bacterial strains used in this study are shown in
Table 1. Campylobacter strains were cultured on Mueller
Hinton Agar (Oxoid, UK), Columbia agar plates (CBA)
(Oxoid, UK) supplemented with either 5% (v/v) horse
blood or with Skirrow selective supplement (Oxoid, UK)
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Scientific, UK) under microaerobic conditions (5% O2,
85% N2, 10% CO2) at 37°C for 24 or 48 h or alternatively
microaerophillic conditions were created using CampyGen
Paks (Fisher Ltd).
Genome sequencing, assembly and annotation
Bacterial cells were harvested and genomic DNA was ex-
tracted using Wizard Genomic DNA Purification Kit
(Promega A1125). Each gDNA sample was quantified
using a Thermo Scientific NanoDrop™ 1000 Spectropho-
tometer and run on a 1.5% agarose gel stained with
SYBR Safe DNA stain. Genome-wide sequence data was
generated for C. coli K3 and K7 (Table 1) using the
Illumina HiSeq 2500 platform. Sequencing reads were
assembled de novo using Velvet [19] using hash lengths
between 39 and 57 and coverage cut-offs between 2 and
10. Assemblies were submitted to the RAST online ser-
ver [23] for annotation.
Carbon utilisation phenotypic microarray assay
C. jejuni and C. coli isolates were cultured from (−80°C)
frozen stocks on Columbia Blood Agar (CBA) containing
5% horse blood (HB) for 48 h at 37°C. Cultures were
transferred onto Mueller Hinton agar and incubated as
before for an additional 48 h. The bacteria were then har-
vested from agar plates and resuspended into IF-0a inocu-
lating fluid (Biolog, Hayward, CA, USA) and adjusted to
16% transmittance (or using an optical density (OD)
measuring device (Turbidimeter, Biolog) a OD600 = 0.8).
The cell suspension was mixed with an additive solution
containing tetrazolium violet (Redox dye D) as a redox in-
dicator dye, PM1 or PM2A additive and water, as per the
manufacturer’s instructions. A final volume of 100 μl was
added to each of the 96 wells in the carbon utilisation
plates, PM1 and PM2A, or bespoke propionic acid only
PM plates (Biolog). Care was taken to carefully maintain
microaerobic conditions at all times, and inoculated PM
plates were placed into gas impermeable bags with a
Campy Gen Compact Sachet (Oxoid, UK) during the
assay. The inoculated PM1 and PM2A plates were imme-
diately placed in an Omnilog automatic plate reader
(Biolog) for incubation at 37°C. Metabolism of the various
carbon sources was recorded every 15 min over a 90 h
period as reduction of the tetrazolium violet dye, produ-
cing a purple colour, indicative of active bacterial res-
piration. The bespoke propionic plates were immediately
placed in a variable atmosphere incubator (VAIN) (Don
Whitley Scientific, UK) under microaerobic conditions
(5% O2, 85% N2, 10% CO2) at 37°C for up to 5 days. Me-
tabolism of propionic acid was recorded daily over five
days as a reduction of the tetrazolium violet dye, pro-
ducing a purple colour, indicative of active bacterial res-
piration. Abiotic negative control plates containing allcomponents except for cells were also analysed. Initially,
we performed the abiotic control experiments to identify
carbon sources that could indicate in false positive results
due to auto- reduction of the dye. False positive results
observed in PM1 were L-arabinose, D-xylose, D-ribose,
L-lyxose. Potential false positive results observed in PM2
were, D-arabinose, 2-deoxy D ribose, D glucosamine,
5-keto D gluconic acid, and dihyroxyacetone. Results for
these carbon sources were subsequently excluded from
further analysis.Bioinformatics analysis
The Kyoto Encyclopaedia of Gene and Genomes (KEGG
(http://www.genome.jp/kegg) was employed to determine
propanoate metabolism pathways to which the proteins
were assigned. The RAST webserver [23] was used to
automatically annotate the genome sequences and to carry
out KEGG pathway comparisons. To search for conserved
regions in the sequences of propionate-CoA ligase and
2-methyl citrate synthase, gene sequences from newly
sequenced C. coli isolates K3 and K7 were aligned with
homologues in C. coli genome sequences available through
the National Center for Biotechnology Information (NCBI)
website available at (http://www.ncbi.nlm.nih.gov/). Ho-
mology searches were performed using the Blastn tools
[25] and multiple sequence alignments were carried out
using the computer software Clone Manager 9 (Cary,
North Carolina USA).Genetic screening for propionate-CoA ligase and 2 methyl
citrate synthase
A 522 bp portion of the propionate-CoA ligase was ampli-
fied using the PCR from 43 strains of C. jejuni DNA and
14 C. coli DNA using the primers PA2 (5′- ATA GGG
TGC TTG ATG ATA GCG ATG GG-3′ and 5′- GAA
GCA TAT TTG CTC TAT ATT GTG GGC GTT-3′). A
843 bp portion of the 2 methyl citrate synthase was ampli-
fied using the PCR from 43 strains of C. jejuni DNA and
14 C. coli DNA using the primers PA1 (5′ – TAA AAA
AAC GGG TGG ATT GGC AGG AGT TAT-3′ and 5′-
GTG CAT TTC TAG GAT CAC CTC CAA GTC-3′. A
250 bp portion of the internal control gene gltA was also
amplified to check the fidelity of the PCR for all Campylo-
bacter strains using the primers gltA (5′ - TAA AAT CCC
TAC TATAGT GGC CAC CG-3′ and 5′GCA TAA GGA
TGA GCA TGA GTT GAA CC-3′). Amplifications were
carried out in a 50 μl reaction mix containing 2-5 μl DNA
and using Red Hot Start Polymerase (Qiagen Ltd) and
then subjected to PCR using the following cycles; for PA1/
PA2 96°C for 15 minutes, followed by 25 cycles of 1 minute
at 94°C, 1.5 min at 59.4°C, 1.5 min at 72°C, and 7 min at
72°C; for gltA 15 min at 96°C, 30 cycles of 1 minute at 94°C,
1 minute at 59.4°C, 1.5 min at 72°C and 7 min at 72°C.
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Additional file 1: Raw data on carbon utilisation of C. jejuni and C.
coli strains using Biolog analysis.
Additional file 2: Comparison of (a) 2-methyl citrate synthase and
(b) propionate-CoA ligase amino acid sequences from C. coli strain.
The amino acid sequences were analysed by computer software Clone
Manager Professional Suite version 9 (Cary, North Carolina USA). Dashed
lines represent gaps generated by the analysis software. The identical
amino acids are shaded in pale green and the strains can be identified
by strain name. The amino acid sequence of 2-methyl citrate synthase
and propionate-CoA ligase proteins can be accessed through the NCBI
protein database under NCBI accession numbers AAFL01000003.1
(RM2228) [18], AEER01000027.1 (JV 20), AIMK01000002.1 (Z163),
AIMJ01000007.1 (90–3), AIML01000019.1 (2548).
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